Acrx stock forecast.

AcelRx Pharmaceuticals (ACRX) Stock Forecast and Price Target 2023 ACRX's current price target is $4.63. Learn why top analysts are making this stock forecast for AcelRx …Sign-up to receive the latest news and ratings for Evogene and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023. Next Earnings (Estimated) +423.4%. $-26,640,000.00.6.51M. ZOMT. 106.30. -1.80%. 108.56M. View the real-time AcelRx (NASDAQ ACRX) share price and assess historical data, charts, technical analysis and the share chat forum.AcelRx Pharmaceuticals, Inc. Common Stock (ACRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

AcelRx Pharmaceuticals, Inc. Common Stock (ACRX) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.Acme United Corporation (ACU) share price prediction for 2023, 2024, 2025, 2026 and 2027. ACU one year forecast. Acme United stock monthly and weekly forecasts.Future criteria checks 1/6. Acerinox is forecast to grow earnings and revenue by 14% and 1.9% per annum respectively. EPS is expected to grow by 14% per annum. Return on equity is forecast to be 11.2% in 3 years.

ACV Auctions Inc. (ACVA) share price prediction for 2023, 2024, 2025, 2026 and 2027. ACVA one year forecast. ACV Auctions stock monthly and weekly forecasts.The stock boasts 4 recent buy ratings vs just 1 hold rating. This is with an $7.75 average price target, suggesting shares could surge 113%. Get the ACRX Stock Research Report.

Find real-time ITRM - Iterum Therapeutics PLC stock quotes, company profile, news and forecasts from CNN Business. Nov 29, 2023 · Iterum Therapeutics plc (NASDAQ:ITRM) released its quarterly earnings results on Friday, November, 12th. The company reported $0.30 EPS for the quarter, missing the consensus estimate of $1.80 by $1.50. During the same period last year, the company earned ($5.10) EPS. View the latest news, buy/sell ratings, SEC filings and insider transactions ... Dec 1, 2023 · AcelRx Pharmaceuticals last issued its earnings data on November 8th, 2023. The specialty pharmaceutical company reported ($0.08) EPS for the quarter, beating analysts' consensus estimates of ($0.29) by $0.21. The company earned $0.12 million during the quarter. AcelRx Pharmaceuticals has generated ($2.23) earnings per share over the last year ... AcelRx Pharmaceuticals ( NASDAQ: ACRX) is scheduled to announce Q1 earnings results on Wednesday, May 10th, after market close. The consensus EPS Estimate is -$0.80 and the consensus Revenue ...

Analyst Forecast. According to 3 analysts, the average rating for SLNO stock is "Strong Buy." The 12-month stock price forecast is $29.67, which is an increase of 3.16% from the latest price.

Nov 29, 2023 · 1 Wall Street research analysts have issued 1-year price targets for Acurx Pharmaceuticals' stock. Their ACXP share price targets range from $13.00 to $13.00. On average, they predict the company's stock price to reach $13.00 in the next twelve months. This suggests a possible upside of 244.8% from the stock's current price.

Find real-time VRNA - Verona Pharma PLC stock quotes, company profile, news and forecasts from CNN Business.AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised ...Stock Price Forecast The 2 analysts offering 12-month price forecasts for Acurx Pharmaceuticals Inc have a median target of 11.50, with a high estimate of 13.00 and a low estimate of 10.00.acrx stock forecast cnn. During the last trading day the stock. Stock Price Forecast According to 8 stock analysts the average 12. Walls… Friday, November 25, 2022 Edit. class melbourne schedule wallpaper. la fitness melbourne fl class schedule. We ...AcelRx Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. ACRX updated stock price target summary.Earnings for AcelRx Pharmaceuticals are expected to decrease in the coming year, from ($0.40) to ($0.65) per share. AcelRx Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 based off prior year's report dates. Read More.AcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Tops Revenue Estimates. by Zacks Equity Research Published on August 10,2023. AcelRx Pharmaceuticals (ACRX) delivered earnings and revenue surprises ...

Future criteria checks 1/6. Acerinox is forecast to grow earnings and revenue by 14% and 1.9% per annum respectively. EPS is expected to grow by 14% per annum. Return on equity is forecast to be 11.2% in 3 years.Investors need to pay close attention to AcelRx (ACRX) stock based on the movements in the options market lately.Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...ACRX stock had an impressive performance on October 20, 2023, with the potential for significant growth in the future. According to data from CNN Money, two analysts offering 12-month price forecasts for AcelRx Pharmaceuticals Inc have a median target of 4.63, with a high estimate of 5.00 and a low estimate of 4.25.Average. 4.63. Current Price. $0.50. Overview. Research & Ratings. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading ... Current. -$0.21. 1 Month Ago. -$0.48. 3 Months Ago. -$0.63. AcelRx Pharmaceuticals Inc. analyst estimates, including ACRX earnings per share estimates and analyst recommendations.

The Inpixon stock price gained 1.45% on the last trading day (Wednesday, 29th Nov 2023), rising from $0.0621 to $0.0630. During the last trading day the stock fluctuated 6.05% from a day low at $0.0612 to a day high of $0.0649. The price has fallen in 6 of the last 10 days and is down by -11.89% for this period.If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...

Nov 29, 2023 · 1 Wall Street research analysts have issued 1-year price targets for Acurx Pharmaceuticals' stock. Their ACXP share price targets range from $13.00 to $13.00. On average, they predict the company's stock price to reach $13.00 in the next twelve months. This suggests a possible upside of 244.8% from the stock's current price. Find real-time CTMX - CytomX Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.Stock Price Forecast. The 5 analysts offering 12-month price forecasts for BioXcel Therapeutics Inc have a median target of 11.00, with a high estimate of 18.00 and a low estimate of 4.00. The ...We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...3.91%. $84.57M. SRNEQ | Complete Sorrento Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.When should I take profit in Acelrx Pharmaceuticals stock? Buy or sell stock? Will ACRX stock price go up? What are analysts’ forecasts for ACRX stock? …ACRX Analyst Estimates Stock Screener Earnings Calendar Sectors Nasdaq | ACRX U.S.: Nasdaq AcelRx Pharmaceuticals Inc. Watch list NEW Set a price target alert After Hours …

Biotech Stock Roundup: RNA Up on BMY Deal Expansion, BIVI Down on Setback & More. Regulatory and pipeline updates from Avidity Biosciences, Inc. (RNA) and BioVie (BIVI) are in the spotlight this week.

Nov 22, 2023 · ACRX has an Altman Z-Score of -27.53 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for AcelRx Pharmaceuticals, Inc. (ACRX) stock, including valuation metrics, financial numbers, share information and more.

CRSP Stock 12 Months Forecast. Based on 16 Wall Street analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. The average price target is $85.25 with a high forecast of $220.00 and a low forecast of $42.00. The average price target represents a 21.84% change from the last price of $69.97.Sep 14, 2023 · ACRX stock forecast Our latest prediction for Acelrx Pharmaceuticals Inc's stock price was made on the Sept. 14, 2023 when the stock price was at 0.88$ . In the short term (2weeks), ACRX's stock price should underperform the market by -3.79% . AcelRx Pharmaceuticals (ACRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). Find the latest AcelRx Pharmaceuticals, Inc. (ACRX) stock quote, history, news and other vital information to help you with your stock trading and investing.Find the latest Energizer Holdings, Inc. (ENR) stock quote, history, news and other vital information to help you with your stock trading and investing.Based on 4 Wall Street analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $21.67 with a high forecast of $47.00 and a low forecast of $8.00. The average price target represents a 452.81% change from the last price of $3.92. Highest Price Target $47.00. Average Price Target $21.67. CRSP Stock 12 Months Forecast. Based on 16 Wall Street analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. The average price target is $85.25 with a high forecast of $220.00 and a low forecast of $42.00. The average price target represents a 21.84% change from the last price of $69.97.Acurx Pharmaceuticals, Inc. Analyst Report: Pfizer Inc. Pfizer is a leading developer and manufacturer of pharmaceuticals and biotech drugs. Its products include oncology and immunology drugs ...Shares used in computing net income (loss) per share of common stock, diluted. 10,924. 7,360. 10,909. 7,321 (1) Includes the following non-cash stock-based compensation expense: Research and ...Find the latest Amarin Corporation plc (AMRN) stock quote, history, news and other vital information to help you with your stock trading and investing.Oct 2, 2023 · AcelRx Pharmaceuticals is forecast to grow earnings and revenue by 11.4% and 63.5% per annum respectively while EPS is expected to grow by 33.4% per annum. The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction. Long term indicators fully support a continuation of the trend. See More Share. ACRX Stock Quotes API . ACRX Related ETF s. Symbol %Holdings 3M %Chg; ACRX -32.11% : Acelrx Pharmaceutica: VTI : 0% +2.97% : Total …

Find real-time GNPX - Genprex Inc stock quotes, company profile, news and forecasts from CNN Business.Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Close Trending Tickers barFind real-time GNPX - Genprex Inc stock quotes, company profile, news and forecasts from CNN Business.Instagram:https://instagram. windows server coursedow components todayotcmkts wsrcsnow stoc Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Marker Therapeutics Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The ... best solar stockexpi stock forecast Cash Ratio forecast for AcelRx Pharmaceuticals (ACRX) stock. Annual Cash Ratio forecast for AcelRx Pharmaceuticals stock for 2021 is 1.08299256789893. It is increase 0.39% from the last annual Cash Ratio report of 1.07883329659834. Annual Cash Ratio forecast for 2022 is 1.07667132533243, and 2023 is 1.07669258943835. new rtx cards AcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Tops Revenue Estimates. by Zacks Equity Research Published on August 10,2023. AcelRx Pharmaceuticals (ACRX) delivered earnings and revenue surprises ...Get a real-time Applied Digital Corporation (APLD) stock price quote with breaking news, financials, statistics, charts and more. Get a real ... the average rating for APLD stock is "Strong Buy." The 12-month stock price forecast is $14.21, which is an increase of 204.28% from the latest price. Price Target. $14.21 (204.28% upside ...